ÂÜÀòÂÒÂ×

Rob May is currently the VP, Head of Business Development and Partner Business at Grünenthal Meds. Prior to this, he served as the VP Head of International Expansion & Partner Management at Kyowa Kirin International plc. His extensive experience includes roles such as VP at Intercept Pharmaceuticals, Managing Director at The Janssen Pharmaceutical Companies of Johnson & Johnson, and various other positions in business development, management, and consulting within the pharmaceutical industry. He holds an MBA from the University of Warwick - Warwick Business School and a BSc in Environmental Science from the University of Plymouth.